Jeff Johnson Analyst PerformanceSenior Research Analyst at Robert W. BairdJeff Johnson is a stock analyst at Robert W. Baird focused in the medical sector, covering 18 publicly traded companies. Over the past year, Jeff Johnson has issued 15 stock ratings, including buy and hold recommendations. While full access to Jeff Johnson's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jeff Johnson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings58 Last 10 YearsBuy Recommendations61.82% 34 Buy RatingsCompanies Covered18 Unique Companies Ratings Distribution55RatingsDistribution of strong buy, buy, hold, and sell ratings by Jeff Johnson.RatingPercentageCount Strong Buy0.0%0 ratings Buy61.8%34 ratings Hold38.2%21 ratings Sell0.0%0 ratingsOut of 55 total stock ratings issued by Jeff Johnson at Robert W. Baird, the majority (61.8%) have been Buy recommendations, followed by 38.2% Hold.Best & Worst CallsBest Call0000.0%ALGNMar 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%INMDOct 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ72.2% of companies on NASDAQ13 companiesNYSE27.8% of companies on NYSE5 companiesJeff Johnson, an analyst at Robert W. Baird, currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies94.4%Miscellaneous1 company5.6%Jeff Johnson of Robert W. Baird specializes in stock coverage within the Medical sector, with additional focus on companies.Coverage IndustriesIndustryPercentageMED PRODUCTS6 companies33.3%MED/DENTAL - SUPP4 companies22.2%MED INSTRUMENTS4 companies22.2%MEDICAL & HOSPITAL EQUIPMENT1 company5.6%MEDICAL DEVICES1 company5.6%Miscellaneous1 company5.6%ELECTROMEDICAL EQUIPMENT1 company5.6% About Jeff JohnsonJeff Johnson is Baird’s Senior Research Analyst covering Medical Technology. In recent years, Jeff has been recognized in the StarMine Analyst Awards by Refinitiv as the No. 2 stock picker in Health Care Equipment & Supplies (2020) and was ranked by TipRanks as the fourth best Wall Street analyst in 2018 and as a Top 100 Wall Street analyst in 2019. Jeff has also been named one of the Top 32 Most Influential People in Dentistry by Incisal Edge for three years running (from 2019-2021). Prior to joining Baird in 2003, Jeff was an optometrist and the associate director of Refractive Surgery Services at the Massachusetts Eye and Ear Infirmary and earlier in his career held positions as an instructor of ophthalmology at Harvard Medical School and an adjunct-assistant professor of optometry at the New England College of Optometry. He received his MBA from Northwestern University, graduated from the Illinois College of Optometry, and did his undergraduate work at the University of Illinois at Urbana-Champaign.Follow on LinkedIn Jeff Johnson's Ratings History at Robert W. Baird Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCOOCooper Companies8/28/2025Lower Price Target$64.87$85.00Outperform$0.0000.00% ROIALCAlcon8/21/2025Lower Price Target$79.29$95.00Outperform$0.0000.00% ROIBBNXBeta Bionics7/30/2025Set Price Target$16.05$17.00Neutral$0.0000.00% ROIHSICHenry Schein7/14/2025Reiterated Rating$73.42$72.00Neutral$0.0000.00% ROICOOCooper Companies5/30/2025Lower Price Target$68.87$97.00Outperform$0.0000.00% ROINVSTEnvista5/27/2025Upgrade$16.73$23.00Outperform$0.0000.00% ROIZBHZimmer Biomet5/6/2025Lower Price Target$90.34$115.00Outperform$0.0000.00% ROINVSTEnvista5/2/2025Set Price Target$17.00$21.00$0.0000.00% ROIDXCMDexCom5/2/2025Lower Price Target$70.26$105.00Outperform$0.0000.00% ROITNDMTandem Diabetes Care5/1/2025Lower Price Target$16.85$24.00Neutral$0.0000.00% ROICOOCooper Companies3/7/2025Lower Price Target$90.98$107.00Outperform$0.0000.00% ROITNDMTandem Diabetes Care2/27/2025Lower Price Target$33.59$33.00Neutral$0.0000.00% ROIALCAlcon2/27/2025Boost Price Target$93.26$108.00Outperform$0.0000.00% ROIBBNXBeta Bionics2/20/2025Initiated Coverage$21.81$20.00Neutral$0.0000.00% ROIDXCMDexCom1/16/2025Upgrade$80.40$104.00Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.